All instruments
Supriya Lifescience Limited
- Stock
- SUPRIYA
- NSE
- ₹695.80−19.99%
- Delayed close, 06 Nov
Details
- INE07RO01027
- Healthcare
- Pharmaceuticals
- Face value ₹2
- Market cap ₹5,600 Cr
Paid for 5 years without a break
Dividend per share by FY
Split-adjusted · FY 2026–27 to date · FY of the ex-date
| Financial year | Total dividend |
|---|---|
| FY 2022–23 | ₹0.60 |
| FY 2023–24 | ₹0.60 |
| FY 2024–25 | ₹0.80 |
| FY 2025–26 | ₹1.00 |
| FY 2026–27 | ₹1.00 |
TTM payout
₹1.00
1 payout in 12 months
Yield
0.14%
Dividend yield · trailing 12 months
52-wk closing range ₹553.35 – ₹1,052.50
Yield and payout totals recalculated 07 Nov 2026.
Came to market
- Listed
- 28 Dec 2021
- 4 years 10 months ago
- Issue price
- ₹274.00
- at the offer
- First dividend
- 8 months
- after listing
Recent payouts
· 5 on record since FY 2022–23| Ex-date | Type | Record date | Amount |
|---|---|---|---|
| 04 Sep 2026 | Final | same day | ₹1.00 |
| 04 Sep 2025 | Final | 05 Sep 2025 | ₹1.00 |
| 20 Sep 2024 | Final | — | ₹0.80 |
| 15 Sep 2023 | Final | — | ₹0.60 |
| 01 Sep 2022 | Final | — | ₹0.60 |
Income calculator
₹143
Expected income per year, before tax, at the current 0.14% yield
≈ 143 shares at ₹695.80, using ₹99,499 of the ₹1,00,000. Based on the last twelve months’ payouts — not a forecast, and dividends are taxed at your own slab rate.
Similar current yields
Same asset type, ordered by distance from this instrument’s published trailing-12-month yield. These are not business-sector peers or recommendations.